Transgene Announces Upcoming Investor Meetings

information fournie par Boursorama CP •31/08/2022 à 17:45

Strasbourg, France, August 31, 2022, 05:45 p.m. CEST – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that Management will participate in the upcoming investor events set out below:

- Pareto Securities, 13th Annual Healthcare Conference – Stockholm, Sweden
September 8, 2022

- Transgene’s R&D Day – Paris, France
September 27, 2022

- Investor Access Forum – Paris, France
October 6 & 7, 2022

- HealthTech Innovation Days 2022 – Paris, France
October 13 & 14, 2022

- EigenKapitalForum – Frankfurt (Main), Germany
November 28, 2022

.../...